FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
-2.48%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$313M
AUM Growth
+$313M
Cap. Flow
+$112M
Cap. Flow %
35.78%
Top 10 Hldgs %
86.61%
Holding
24
New
2
Increased
7
Reduced
3
Closed
2

Top Buys

1
AIMT
Aimmune Therapeutics, Inc.
AIMT
$104M
2
RGLS
Regulus Therapeutics
RGLS
$5.6M
3
XLRN
Acceleron Pharma Inc.
XLRN
$4.17M
4
RGNX icon
Regenxbio
RGNX
$3.45M
5
AERI
Aerie Pharmaceuticals, Inc.
AERI
$1.79M

Top Sells

1
JUNO
Juno Therapeutics, Inc.
JUNO
$4.88M
2
SCYX icon
SCYNEXIS
SCYX
$2.12M
3
BITI
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$1.41M
4
AGRX
Agile Therapeutics, Inc
AGRX
$428K
5
QTNT
Quotient Limited Ordinary Shares
QTNT
$92.7K

Sector Composition

1 Healthcare 61.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$104M 31.43%
+4,087,900
New +$104M
KDNY
2
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$40.8M 12.39%
2,106,734
– –
LRMR icon
3
Larimar Therapeutics
LRMR
$310M
$25.9M 7.87%
811,300
– –
ADAP
4
Adaptimmune Therapeutics
ADAP
$15.6M
$21M 6.39%
1,757,268
– –
UAM
5
DELISTED
Universal American Corp
UAM
$19.3M 5.85%
2,814,883
– –
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$16.1M 4.88%
906,317
+101,100
+13% +$1.79M
EPZM
7
DELISTED
Epizyme, Inc
EPZM
$13M 3.94%
1,009,795
+111,932
+12% +$1.44M
RGLS
8
DELISTED
Regulus Therapeutics
RGLS
$11.4M 3.48%
1,750,269
+856,488
+96% +$5.6M
ALDR
9
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$11.3M 3.43%
344,770
– –
ARDX icon
10
Ardelyx
ARDX
$1.53B
$8.94M 2.71%
517,290
– –
OREX
11
DELISTED
Orexigen Therapeutics, Inc.
OREX
$8.92M 2.71%
4,225,047
+25,000
+0.6% +$52.8K
NSTG
12
DELISTED
NanoString Technologies, Inc.
NSTG
$7.43M 2.26%
464,486
– –
XLRN
13
DELISTED
Acceleron Pharma Inc.
XLRN
$4.95M 1.5%
198,717
+167,617
+539% +$4.17M
BDSI
14
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$4.9M 1.49%
881,562
+169,284
+24% +$941K
QTNT
15
DELISTED
Quotient Limited Ordinary Shares
QTNT
$3.79M 1.15%
291,229
-7,131
-2% -$92.7K
RGNX icon
16
Regenxbio
RGNX
$451M
$3.45M 1.05%
+156,741
New +$3.45M
NVET
17
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$2.58M 0.78%
708,332
– –
SCYX icon
18
SCYNEXIS
SCYX
$34.9M
$2.46M 0.75%
337,177
-290,978
-46% -$2.12M
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$1.59M 0.48%
76,801
+2,416
+3% +$49.9K
BITI
20
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
$1.06M 0.32%
80,883
-108,017
-57% -$1.41M
SIOX
21
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$840K 0.26%
65,000
– –
AGRX
22
DELISTED
Agile Therapeutics, Inc
AGRX
– –
-49,870
Closed -$428K
JUNO
23
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-91,575
Closed -$4.88M
ANAC
24
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
– –
0
– –